Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company” or 'Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or 'Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial ...

Lockheed Martin re-enters deep-sea mining in lucrative Pacific Ocean zone, negotiating partnerships for access to valuable ...

Ardelyx (ARDX) is emerging as a compelling, yet risky, small-cap biotech opportunity. The company has made significant ...

Stock market today: 36 stocks hit 52-week lows, 150 stocks at 52-week high as Nifty 50, Sensex snap 4-day losing streak to end in green ...

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Saldanha said he hasn’t yet fully figured out how to deploy much of the proceeds of the licensing deal, but added that he ...

Oversea Chinese Banking Corp Ltd acquired a $30.17 million stake in Regeneron Pharmaceuticals during the first quarter, ...

About This EventArtiva Biotherapeutics (Nasdaq: ARTV), visits the Nasdaq MarketSite in Times Square. Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe, and ...

International companies are increasingly inking licensing deals with Chinese biotechs as concerns regarding drug pricing and ...